PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
A Multiple Dose Study Of PF-06678552 In Healthy Subjects
- First Posted Date
- 2014-03-06
- Last Posted Date
- 2014-07-31
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 38
- Registration Number
- NCT02079922
- Locations
- 🇧🇪
Pfizer Investigational Site, Brussels, Belgium
A Study Of PF-06647263 In Patients With Advanced Solid Tumors
- First Posted Date
- 2014-03-05
- Last Posted Date
- 2019-04-29
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 60
- Registration Number
- NCT02078752
- Locations
- 🇺🇸
Huntsman Cancer Hospital / University of Utah, Salt Lake City, Utah, United States
🇺🇸Huntsman Cancer Institute-University of Utah, Salt Lake City, Utah, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06372865 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)
- First Posted Date
- 2014-02-25
- Last Posted Date
- 2014-08-18
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 50
- Registration Number
- NCT02070289
- Locations
- 🇧🇪
Pfizer Investigational Site, Brussels, Belgium
Study To Evaluate Safety And Tolerability Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male Subjects
- First Posted Date
- 2014-02-25
- Last Posted Date
- 2018-11-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 72
- Registration Number
- NCT02070939
- Locations
- 🇺🇸
New Haven Clinical Research Unit, New Haven, Connecticut, United States
A Study To Observe Safety And Blood Concentrations Of PF-06649751 During And Following The Oral Administration Of Multiple Doses Of PF-06649751 In Healthy Adult Western and Japanese Volunteers
- First Posted Date
- 2014-02-20
- Last Posted Date
- 2015-06-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 77
- Registration Number
- NCT02066909
- Locations
- 🇺🇸
New Haven Clinical Research Unit, New Haven, Connecticut, United States
A Study To Investigate Palbociclib (PD-0332991) Pharmacokinetics In Healthy Subjects Of Japanese Descent Relative To Healthy Non-Asian Subjects, And To Determine If Changes In Palbociclib Dose Result In Proportional Changes In Palbociclib Plasma Exposure In Japanese Subjects
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2014-02-11
- Last Posted Date
- 2014-06-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 27
- Registration Number
- NCT02059330
- Locations
- 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States
A Drug Interaction Study Between Bosutinib And Aprepitant In Healthy Volunteers
- First Posted Date
- 2014-02-10
- Last Posted Date
- 2014-06-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 20
- Registration Number
- NCT02058277
- Locations
- 🇺🇸
Pfizer Investigational Site, DeLand, Florida, United States
A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy
- Conditions
- LMNA-Related Dilated Cardiomyopathy
- Interventions
- Drug: ARRY-371797, p38 inhibitor; oral
- First Posted Date
- 2014-02-07
- Last Posted Date
- 2020-10-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT02057341
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸The Ohio State University, Columbus, Ohio, United States
🇺🇸Johns Hopkins University, Baltimore, Maryland, United States
Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects
- Conditions
- Hypercholesterolemia
- Interventions
- First Posted Date
- 2014-02-05
- Last Posted Date
- 2019-02-08
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 218
- Registration Number
- NCT02055976
- Locations
- 🇯🇵
Maebashi Hirosegawa Clinic, Maebashi, Gunma, Japan
🇯🇵Heishinkai Medical Group Incorporated ToCROM Clinic, Shinjuku-ku, Tokyo, Japan
🇯🇵Yokohama Minoru Clinic, Yokohama, Kanagawa, Japan
A 6-Week Study To Determine The Safety And Effect Of An Investigational Drug On Adults With Type 2 Diabetes Mellitus Taking Metformin
- First Posted Date
- 2014-02-03
- Last Posted Date
- 2016-05-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 13
- Registration Number
- NCT02053103
- Locations
- 🇺🇸
Pfizer Investigational Site, Orlando, Florida, United States